Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology International
Published in: Diabetology International 4/2020

01-10-2020 | Febuxostat | Correction

Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Authors: Hitomi Komatsu, Mariko Enomoto, Hisashi Shiraishi, Yasuyo Morita, Daisuke Hashimoto, Shuichi Nakayama, Shogo Funakoshi, Seiki Hirano, Yoshio Terada, Mitsuhiko Miyamura, Shimpei Fujimoto

Published in: Diabetology International | Issue 4/2020

Login to get access

Excerpt

In the original publication, the unit of C-peptide immunoreactivity (CPR) in Table 1 was published incorrectly. The correct unit is ng/ml. …
Metadata
Title
Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes
Authors
Hitomi Komatsu
Mariko Enomoto
Hisashi Shiraishi
Yasuyo Morita
Daisuke Hashimoto
Shuichi Nakayama
Shogo Funakoshi
Seiki Hirano
Yoshio Terada
Mitsuhiko Miyamura
Shimpei Fujimoto
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
Diabetology International / Issue 4/2020
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-020-00436-8

Other articles of this Issue 4/2020

Diabetology International 4/2020 Go to the issue

Original Article

Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes

Mini-Review

Genetics of fulminant type 1 diabetes

Mini-Review

Fulminant type 1 diabetes: recent research progress and future prospects

Commentary

Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000

Mini-Review

Possible involvement of autoimmunity in fulminant type 1 diabetes

Original Article

Effect of a 6-week strength-training program on neuromuscular efficiency in type 2 diabetes mellitus patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits